Max-Planck-Institute for Multidisciplinary Sciences, Göttingen, Germany.
State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Allergy. 2023 May;78(5):1148-1168. doi: 10.1111/all.15678. Epub 2023 Feb 26.
Tremendous progress in the last few years has been made to explain how seemingly harmless environmental proteins from different origins can induce potent Th2-biased inflammatory responses. Convergent findings have shown the key roles of allergens displaying proteolytic activity in the initiation and progression of the allergic response. Through their propensity to activate IgE-independent inflammatory pathways, certain allergenic proteases are now considered as initiators for sensitization to themselves and to non-protease allergens. The protease allergens degrade junctional proteins of keratinocytes or airway epithelium to facilitate allergen delivery across the epithelial barrier and their subsequent uptake by antigen-presenting cells. Epithelial injuries mediated by these proteases together with their sensing by protease-activated receptors (PARs) elicit potent inflammatory responses resulting in the release of pro-Th2 cytokines (IL-6, IL-25, IL-1β, TSLP) and danger-associated molecular patterns (DAMPs; IL-33, ATP, uric acid). Recently, protease allergens were shown to cleave the protease sensor domain of IL-33 to produce a super-active form of the alarmin. At the same time, proteolytic cleavage of fibrinogen can trigger TLR4 signaling, and cleavage of various cell surface receptors further shape the Th2 polarization. Remarkably, the sensing of protease allergens by nociceptive neurons can represent a primary step in the development of the allergic response. The goal of this review is to highlight the multiple innate immune mechanisms triggered by protease allergens that converge to initiate the allergic response.
在过去的几年中,人们在解释看似无害的来自不同来源的环境蛋白如何能诱导强烈的 Th2 偏向性炎症反应方面取得了巨大进展。趋同的研究结果表明,具有蛋白水解活性的过敏原在过敏反应的起始和进展中起着关键作用。某些变应原蛋白酶通过激活 IgE 非依赖性炎症途径,被认为是自身和非蛋白酶变应原致敏的启动子。蛋白酶过敏原降解角蛋白细胞或气道上皮细胞的连接蛋白,以促进过敏原穿过上皮屏障的传递,随后被抗原呈递细胞摄取。这些蛋白酶介导的上皮损伤,以及它们被蛋白酶激活受体(PARs)的感知,引发强烈的炎症反应,导致 Th2 细胞因子(IL-6、IL-25、IL-1β、TSLP)和危险相关分子模式(DAMPs;IL-33、ATP、尿酸)的释放。最近,研究表明蛋白酶过敏原可切割 IL-33 的蛋白酶传感器结构域,产生一种超活性形式的警报素。同时,纤维蛋白原的蛋白水解切割可触发 TLR4 信号,而各种细胞表面受体的切割进一步塑造了 Th2 极化。值得注意的是,伤害感受神经元对蛋白酶过敏原的感知可能是过敏反应发展的一个主要步骤。本文的目的是强调蛋白酶过敏原引发的多种先天免疫机制,这些机制汇聚在一起启动过敏反应。
Int J Mol Sci. 2025-6-13
Clin Rev Allergy Immunol. 2025-6-18
Curr Issues Mol Biol. 2025-2-9
Curr Opin Immunol. 2024-12
Curr Allergy Asthma Rep. 2024-11
ACS Pharmacol Transl Sci. 2022-8-12
Front Mol Biosci. 2022-6-16
Biochem Biophys Res Commun. 2022-2-5
Annu Rev Immunol. 2022-4-26